The crucial factor that plays important role in diagnosis and prompt treatment management of cervical cancer is staging. To stage cervical carcinoma Magnetic Resonance Imaging (MRI) is considered to be the most accurate and gold standard diagnostic tool. Objective: The aim of the present study was to elaborate the diagnostic accuracy of MRI in correlation with Histopathological Examination (HPE). Methods: The 53 patients diagnosed with cervical carcinoma attending the gynecology department of hospital from May 2021 to April 2022 were included in the study. Those patients who had undergone the abdomen and pelvis MRI fulfilled the inclusion criteria. The MRI and histopathological examination not only help in staging of cancer but also consider valuable in tracking tumor location, size and extension. The retroperitoneal lymphadenopathy, and involvement of the tumor to the adjacent areas was also evaluated by the study. Staging of all patient was done according to the International Federation of Gynecology and Obstetrics FIGO standards. Findings of MRI and HPE were assessed. For statistical evaluation of data, the SPSS version 22.0 was used.  For quantitative variables the values were represented as mean with standard deviations. Results: The 54.46±9.29 years was the calculated mean age. Squamous cell carcinoma was diagnosed in almost 46 patients (87.5% cases). Stage IB carcinoma was diagnosed in almost 47.91% cases. Pelvic lymphadenopathy was observed in 8.34% cases, while metastasis of pelvic nodal lymph was observed in 4.16% cases on the HPE. Conclusion: Malignant diseases require early and accurate tool for their diagnosis. For identification of cancer stage and better planning of treatment of cervical carcinoma the highly non-invasive modality MRI can be used. With the advents in MR imaging, it is considered as gold standard diagnostic tool with better sensitivity, specificity and high accuracy for cervical carcinoma.

Objective: This prospective study was conducted to find the maternal outcomes of pregnancy in women with a previous one C-Section in terms of mode of delivery and maternal complication Material & Methods: This prospective cross sectional study was carried out in QHAMC Nowshera from July 2018 to June 2019. A convenient sample of 180 women, all booked and unbooked, with gestational age 37 weeks or more, singleton fetus and cephalic presentation that came to Gynae OPD with history of previous one C/section were included . Informed consent was taken after explaining risks and benefits of planned repeat c/section and VBAC .While those having IUD, placenta previa, breech presentation or gestational age less than 37 weeks were excluded. Data was obtained on pre- designed structured proforma .SPSS 17 software was used for statistical purposes. Results: Results showed that of the total participants 71.1 % had undergone C-section again, and 28.8 % delivered as VBAC. 34.3% of the total C-sections were emergency lower segment C-sections and 65.6% were planned repeat C-sections. Conclusions: It is concluded from our study that VBAC is a safe option for patient with previous one scar with minimal morbidity and no mortality but required good antenatal assessment one to one care and vagilant monitoring with quick resumption to emergency csection when required